Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia

被引：16

作者：

Ezeh, C

Ugochukwu, CC

Weinstein, J

Okpala, I ^{[1
]}

机构：

[1] St Thomas Hosp, Dept Haematol, London SE1 7EH, England

[2] London Bridge Hosp, Dept Pathol, London, England

[3] NESCOT, Dept Appl Sci, Surrey, England

来源：

EUROPEAN JOURNAL OF HAEMATOLOGY | 2005年 / 74卷 / 01期

关键词：

D O I：

10.1111/j.1600-0609.2004.00337.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：86 / 88

页数：3

共 20 条

[1] Anemia of inflammation: the cytokine-hepcidin link
Andrews, NC
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1251 - 1253
[2] Anyaegbu CC, 1998, EUR J HAEMATOL, V60, P267
[3] Effect of α-globin genotype on the pathophysiology of sickle cell disease
Ballas, SK
[J]. PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2001, 20 (02): : 107 - 121
[4] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T
[J]. BLOOD, 2003, 102 (03) : 783 - 788
[5] ACUTE-PHASE REACTANTS AND SEVERITY OF HOMOZYGOUS SICKLE-CELL DISEASE
HEDO, CC
AKENOVA, YA
OKPALA, IE
DUROJAIYE, AO
SALIMONU, LS
[J]. JOURNAL OF INTERNAL MEDICINE, 1993, 233 (06) : 467 - 470
[6] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A
Neitz, S
Mägert, HJ
Schulz, A
Forssmann, WG
Schulz-Knappe, P
Adermann, K
[J]. FEBS LETTERS, 2000, 480 (2-3) : 147 - 150
[7] Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients
Makis, AC
Hatzimichael, EC
Mavridis, A
Bourantas, KL
[J]. ACTA HAEMATOLOGICA, 2000, 104 (04) : 164 - 168
[8] Moran M C, 1995, Am J Orthop (Belle Mead NJ), V24, P18
[9] Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E
Valore, EV
Territo, M
Schiller, G
Lichtenstein, A
Ganz, T
[J]. BLOOD, 2003, 101 (07) : 2461 - 2463
[10] IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Nemeth, E
Rivera, S
Gabayan, V
Keller, C
Taudorf, S
Pedersen, BK
Ganz, T
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1271 - 1276

← 1 2 →